Founded in 1980, Remedica Ltd is the first pharmaceutical company established in Cyprus and a pioneering force in delivering affordable, high-quality healthcare solutions worldwide. With deep-rooted expertise and a strong commitment to innovation, Remedica ltd stands out for its dedication to quality, service, and value—benefiting both patients and partners across the globe.

Operations

Remedica specializes in the development, manufacturing, and distribution of high-quality generic pharmaceutical products, covering a broad spectrum of therapeutic categories, including:

• Oncology
• Antibiotics
• Analgesics
• Cardiovascular medicines
• Central Nervous System agents
• Gastrointestinal treatments
• Diuretics
• Antihistamines
• Antidiabetics
• Anti-Parkinson agents
• Hormones and synthetic substitutes
• Vitamins
• Cough and expectorant remedies

Its products are available in a wide range of dosage forms such as tablets, capsules, creams, ointments, aerosols, suppositories, liquids, and powders. Through a carefully selected global network of distributors, Remedica Ltd exports to more than 70 countries worldwide.

Vision & Growth

Remedica Ltd is committed to continuous growth, driven by innovation, advanced technologies, automation, and digital transformation. Strategic investments in infrastructure, equipment, technology, and human capital have been key to the company’s success—and will continue to fuel its sustainable development in the years ahead.

Limassol Industrial Estate Aharnon Street,
P.O. Box 51706 3508 Limassol, Cyprus

https://www.remedica.eu

The post Remedica Ltd appeared first on PHARMAHOUSE L.T.D..

Polfa Tarchomin S.A., headquartered in Warsaw, is one of the largest generic pharmaceutical companies in Poland and among the oldest pharmaceutical manufacturers in the world, with a history dating back to 1823.

Industry Leadership

Today, Polfa Tarchomin is recognized as a leading force in the field of anti-infective medicines. The company also maintains a strong presence in key therapeutic areas such as insulin-based treatments, psychotropic drugs, and dermatological products.

Diverse Portfolio

With more than 100 high-quality pharmaceutical products (Rx), over-the-counter (OTC) medications, and dermocosmetics, the company offers comprehensive therapeutic solutions. All products are available in appropriate forms and dosage schemes, ensuring optimal efficacy with minimal side effects for patients.

Commitment to Quality

With nearly two centuries of experience and expertise, Polfa Tarchomin S,A continues to set benchmarks in pharmaceutical manufacturing, blending tradition with innovation to meet the evolving needs of modern healthcare.

https://www.polfa-tarchomin.com.pl

The post Polfa Tarchomin S.A. appeared first on PHARMAHOUSE L.T.D..

DANHSON Pharmaceutical Company is a dynamically growing pharmaceutical company based in Bulgaria. It was founded in 2015 by professionals with extensive experience in the pharmaceutical sector.

Activities

Our core activities include the development, production, and marketing of pharmaceutical products (RX and OTC), dietary supplements, and cosmetics. With a strong focus on quality and innovation, we offer solutions that meet the modern needs of the market and patients.

Growth Strategy

DANHSON is steadily evolving through the acquisition of established companies and targeted production investments. By combining expertise, experience, and technological excellence, we ensure high-level services for the end consumer.

Production Specialization

The company specializes in the manufacturing of:

• Sterile small-volume solutions (ampoules)

• Non-sterile oral liquids 

• Semi-solid forms (gels, ointments)

• Biologically active liquid products for external use (shampoos)

• Solid oral dosage forms (tablets, capsules)

With modern facilities and strict quality standards, DANHSON delivers reliable and effective products that meet the demands of the international pharmaceutical market.

https://danhson.bg/en/home/

The post DANHSON Pharmaceutical Company appeared first on PHARMAHOUSE L.T.D..

CHEPLAPHARM Arzneimittel GmbH was founded in 1998 in Freiburg (Breisgau) and, since 2003, has been headquartered in Mesekenhagen, in the state of Mecklenburg-Vorpommern, near the Baltic Sea.

The company is composed of a dedicated team of experienced and specialized professionals, committed to providing high-quality pharmaceutical products, dietary supplements, and cosmetics. Strict quality control and the implementation of the most advanced pharmaceutical technologies form the foundation of its production process.

CHEPLAPHARM defines itself as a European supplier of specialized pharmaceutical formulations, focusing on therapeutic agents and conditions that represent a small share of global pharmaceutical activity—offering solutions where there is genuine need.

Through this specialization, the company has secured a unique position in the global market. It has consistently recorded strong and impressive growth in its turnover since its establishment.

Vision

We envision a world where every patient has access to reliable and specialized treatments, regardless of the rarity or complexity of their condition. Our ambition is to be the leading partner in the field of specialized pharmaceutical products, strengthening the sustainability of healthcare systems and promoting responsible pharmaceutical innovation.

Address: Bahnhofstr. 1a, 17498 Mesekenhagen, Germany

www.cheplapharm.com

The post CHEPLAPHARM ARZNEIMITTEL GmbH appeared first on PHARMAHOUSE L.T.D..